Cargando…

Profiling of Ecstasy Tablets Seized in Iran

In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Khajeamiri, Ali Reza, Kobarfard, Farzad, Ahmadkhaniha, Reza, Mostashari, Gelareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828921/
https://www.ncbi.nlm.nih.gov/pubmed/24250345
_version_ 1782291309981073408
author Khajeamiri, Ali Reza
Kobarfard, Farzad
Ahmadkhaniha, Reza
Mostashari, Gelareh
author_facet Khajeamiri, Ali Reza
Kobarfard, Farzad
Ahmadkhaniha, Reza
Mostashari, Gelareh
author_sort Khajeamiri, Ali Reza
collection PubMed
description In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these tablets, color tests (Marquis test, Simon’s test, Chen’s test and Gallic acid test), Thin Layer Chromatography (TLC), anion test, residual solvents, Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were carried out on the tablets. The range of tablets weight was 96–308 mg and the range of 3,4-methylenedioxymethamphetamine (MDMA) hydrochloride content in these tablets was 60–180 mg. No good correlation was found between the tablets weight and their MDMA contents. All of the tablets containing MDMA had this compound in hydrochloride form. Ketamine, phenmetrazine and ephedrine (or pseudoephedrine) were found in some of the tablets along with MDMA. No MDMA was found in 20% of the tablets. Some of these tablets contained compounds such as caffeine or tramadol as their active ingredient.
format Online
Article
Text
id pubmed-3828921
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-38289212013-11-18 Profiling of Ecstasy Tablets Seized in Iran Khajeamiri, Ali Reza Kobarfard, Farzad Ahmadkhaniha, Reza Mostashari, Gelareh Iran J Pharm Res Original Article In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these tablets, color tests (Marquis test, Simon’s test, Chen’s test and Gallic acid test), Thin Layer Chromatography (TLC), anion test, residual solvents, Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were carried out on the tablets. The range of tablets weight was 96–308 mg and the range of 3,4-methylenedioxymethamphetamine (MDMA) hydrochloride content in these tablets was 60–180 mg. No good correlation was found between the tablets weight and their MDMA contents. All of the tablets containing MDMA had this compound in hydrochloride form. Ketamine, phenmetrazine and ephedrine (or pseudoephedrine) were found in some of the tablets along with MDMA. No MDMA was found in 20% of the tablets. Some of these tablets contained compounds such as caffeine or tramadol as their active ingredient. Shaheed Beheshti University of Medical Sciences 2011 /pmc/articles/PMC3828921/ /pubmed/24250345 Text en © 2011 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Khajeamiri, Ali Reza
Kobarfard, Farzad
Ahmadkhaniha, Reza
Mostashari, Gelareh
Profiling of Ecstasy Tablets Seized in Iran
title Profiling of Ecstasy Tablets Seized in Iran
title_full Profiling of Ecstasy Tablets Seized in Iran
title_fullStr Profiling of Ecstasy Tablets Seized in Iran
title_full_unstemmed Profiling of Ecstasy Tablets Seized in Iran
title_short Profiling of Ecstasy Tablets Seized in Iran
title_sort profiling of ecstasy tablets seized in iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828921/
https://www.ncbi.nlm.nih.gov/pubmed/24250345
work_keys_str_mv AT khajeamirialireza profilingofecstasytabletsseizediniran
AT kobarfardfarzad profilingofecstasytabletsseizediniran
AT ahmadkhanihareza profilingofecstasytabletsseizediniran
AT mostasharigelareh profilingofecstasytabletsseizediniran